MedTrace Logo

WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up

NCT07181317 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 314

Last updated 2026-01-12

No results posted yet for this study

Summary

The WAMIF study was conducted from 2017 to 2019, including 314 patients in 30 French research centers spread across metropolitan France. It systematically collected the clinical, morphological, and biological characteristics of myocardial infarction cases affecting women under 50 years of age and assessed their short-term (in-hospital) and medium-term (12-month) prognosis. Extending the follow-up beyond 12 months for this first study would provide fundamental data for understanding and improving the care of these patients.

Conditions

  • Myocardial Infarction, Acute

Interventions

OTHER

Questionnaires

Assessment of stress and anxiety and quality of life after myocardial infarct: * Stress score: Perceived Stress Scale-4 (PSS-4) * Anxiety score: Generalized Anxiety Disorder-7 (GAD-7) * Depression score: Patient Health Questionnaire-9 (PHQ-9) * Quality of life scores: European Quality of Life-5 Dimensions (EQ-5D) and 12-Item Short-Form General Health Survey (SF-12)

OTHER

Major events

Collection of information related to major events occurring since inclusion in the WAMIF study

Sponsors & Collaborators

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Stéphane MANZO SILBERMAN, MD · Hôpital de la Pitié-Salpêtrière, APHP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-25
Primary Completion
2029-09-30
Completion
2029-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07181317 on ClinicalTrials.gov